Shin Saito, MD/PhD came to the Uppaluri lab in 2021 from the Keio University School of Medicine Department of Otolaryngology. His research at Keio was on the impact of COX-2  on cancer stemness. He is focused on understanding neoantigen biology in MOC HNSCC models including in anti-PD1 resistant settings.

---